Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

for
Solid Tumors
Location: Fairfax VA, Grand Rapids MI, Minneapolis MN, Houston TX,
Sponsor: Adcentrx Therapeutics

Sex: All

Age: 18+

Code: NCT06710379

Phase 1, Recruiting

First in Human, Dose Escalation Study of AN4005

for
Advanced Solid Tumor, Advanced Lymphoma
Location: The Bronx NY, Hackensack NJ, Fairfax VA, Greenville SC
Sponsor: Adlai Nortye Biopharma Co., Ltd.

Sex: All

Age: 18+

Code: NCT04999384

Phase 1, Recruiting

Improving Quality of Life for Patients With Breast Cancer Invading the Chest Wall: A Prospective Registry For Patients Undergoing Full Thickness Chest Wall Resection

for
Breast Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT03265379

Recruiting

TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer

for
Breast Carcinoma, Cardiomyopathy, Congestive Heart Failure
Location: Jacksonville FL, Gainesville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05507879

Recruiting

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

for
Pediatric Brain Tumor, Pediatric Solid Tumor
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 6 - 21

Code: NCT05521984

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection

for
Solid Tumor
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT05585684

Recruiting

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

for
Breast Cancer
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT06127979

Recruiting

A Survey of Physician and Molecular Tumor Board Perspectives on the Clinical Utility and Usability of Cellworks Singula™ and Ventura™ Reports in Facilitating Patient Treatment Decisions for Pan-Cancer Patients

for
Pan-cancer
Location: Sioux Falls SD
Sponsor: Avera McKennan Hospital & University Health Center

Sex: All

Age: 0+

Code: NCT05308784

Recruiting

Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type

for
Cancer, Smoking
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06484179

Recruiting

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

for
Breast Cancer, Breast Cancer Recurrent
Location: Montreal, New York NY, Richmond VA, Oshawa, Toronto,
Sponsor: University Health Network, Toronto

Sex: Female

Age: 18 - 70+

Code: NCT05592938

Recruiting

A Single Arm Pilot Trial of a Social Network Intervention

for
Cancer
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 60+

Code: NCT05745038

Recruiting

Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction

for
Malignant Solid Neoplasm
Location: Philadelphia PA, Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06306638

Phase 1, Phase 2, Recruiting

Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling

for
HER2-negative Breast Cancer
Location: Newark NJ, Baltimore MD, York PA, Mechanicsville VA,
Sponsor: NSABP Foundation Inc

Sex: Female

Age: 18+

Code: NCT03412643

Phase 2, Recruiting

Safety Study of Camptothecin-20-O-Propionate Hydrate (CZ48)

for
Malignant Lymphoma of Extranodal and/or Solid Organ Site,
Location: San Antonio TX
Sponsor: Cao Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT02575638

Phase 1, Recruiting

Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST-2): A Randomized Phase II/III Trial

for
Metastatic Cancer
Location: Montreal, London
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Sex: All

Age: 18+

Code: NCT05508464

Recruiting

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

for
Diabetes, Cholesterol, Cancer, Blood Pressure Disorders,
Location: Bryan TX
Sponsor: Texas A&M University

Sex: All

Age: 18+

Code: NCT06726590

Recruiting

Dose Escalation and Expansion Study Evaluating ODC-IL2 in Adult Patients With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumors, Metastatic Solid Tumors
Location: Scottsdale AZ
Sponsor: Trutino Biosciences Inc.

Sex: All

Age: 18+

Code: NCT06770764

Phase 1, Recruiting

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

for
Breast Cancer
Location: Burlington MA, Providence RI, Quebec, Stony Brook NY,
Sponsor: Exact Sciences Corporation

Sex: All

Age: 18+

Code: NCT06401421

Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Boston MA, New Haven CT, New York NY, Tampa FL,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06917079

Phase 1, Recruiting

De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You

for
Breast Cancer
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 18 - 70+

Code: NCT05134779

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial